Revenue Update on MusclePharm(OTCMKTS:MSLP)

MusclePharm(OTCMKTS:MSLP) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Company reported revenue of $32.87M. Analysts estimated a revenue of $42.91M. Earnings per share were $-0.30.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

MusclePharm - Is it time to Sell?

Top Brokerage Firms are advising their investors on MusclePharm. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.